BioAmber Inc. Deferred Tax Assets, Valuation Allowance
BioAmber Inc. had Deferred Tax Assets, Valuation Allowance of $66.97 million as of 2017-12-31, per its 10-K filed 2018-03-30.
Discontinued › Notes › Income Taxes › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2018-03-30
- 2017-12-31: Deferred Tax Assets, Valuation Allowance $66.97M.
- 2016-12-31: Deferred Tax Assets, Valuation Allowance $62.69M.
- 2015-12-31: Deferred Tax Assets, Valuation Allowance $58.26M.
- 2014-12-31: Deferred Tax Assets, Valuation Allowance $50.28M.
| Period end | Deferred Tax Assets, Valuation Allowance |
|---|---|
| 2017-12-31 | $66.97M 10-K · filed 2018-03-30 |
| 2016-12-31 | $62.69M 10-K · filed 2018-03-30 |
| 2015-12-31 | $58.26M 10-K · filed 2017-03-16 |
| 2014-12-31 | $50.28M 10-K · filed 2016-03-15 |
| 2013-12-31 | $40.37M 10-K · filed 2015-03-16 |
| 2012-12-31 | $24.40M 10-K · filed 2014-03-28 |